Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Doseology Sciences DOSEF


Primary Symbol: C.MOOD

Doseology Sciences Inc is a diversified life sciences company, on a mission to reimagine mental health therapies through innovation, technology and sustainability. With a focus on psychedelic and non-psychedelic compounds, Doseology offers cutting edge therapeutic products and services, with the aim of making a meaningful impact on the mental health pandemic and improving overall health.


Recent & Breaking News (CSE:MOOD)

    Doseology Sciences (CSE:MOOD) expands into Whole Foods

    Simon Druker  5 days ago

    Doseology Goes National with Whole Foods Market

    Canada NewsWire 5 days ago

    Doseology Expands into National Retailer Sobeys

    Canada NewsWire 7 days ago

    Doseology Launches in 31 Healthy Planet Locations Across Ontario

    Canada NewsWire October 11, 2022

    Doseology To Attend CHFA NOW Show, Sept 17-18

    Canada NewsWire September 13, 2022

    Doseology Targets Digital Nomads

    Canada NewsWire August 25, 2022

    Doseology Products Now Available on Retail Shelves

    Canada NewsWire August 4, 2022

    Doseology Sciences (CSE:MOOD) expands into U.S. retail market

    Dave Jackson July 14, 2022

    Doseology Expands into US Retail Market

    Canada NewsWire July 14, 2022

    Doseology Uplists to OTCQB Market in USA

    PR Newswire July 6, 2022

    Doseology Opens to American Investors

    PR Newswire June 1, 2022

    Doseology Launches Medicinal Mushroom Product Line in Canada to Supply Increasing Demand

    PR Newswire February 23, 2022

    Doseology Names CFO and Appoints New Board Member

    PR Newswire January 28, 2022

    Doseology Appoints Maryam Marissen as CEO to Prepare for Next Growth Stage

    PR Newswire January 13, 2022

    Doseology Completes Development and Test Marketing of Adaptogenic Mushroom Product Line

    PR Newswire January 6, 2022

    Doseology Prepares to Expand Mushroom Production by Hiring Dr. Wellman-Labadie to Oversee Planned Research and Development Laboratory

    PR Newswire December 15, 2021

    Doseology Prepares for Growth Phase in Psychedelic-Focused Mental Health Market, Completes Dealer's License Application

    PR Newswire December 6, 2021

    Doseology Set to Trade CSE: MOOD

    TheNewsWire November 15, 2021